Oseltamivir
From Proteopedia
|
Better Known as: Tamiflu
- Marketed By:
- Major Indication: Influenza Infection
- Drug Class: Neuraminidase Inhibitor
- Date of FDA Approval:
- 2009 Sales: $3.1 Billion
- Importance:
- See Pharmaceutical Drugs for more information about other drugs and diseases.
Mechanism of Action
H274Y
Pharmacokinetics
For References to Pharmacokinetic data, see: References |
References